Patient
SITE006-0123
completed Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE006 (GBR) (Dr. Rossi)
consented 2026-01-27
Adverse events
4
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 4
Grade 2 Nausea — outcome: RECOVERED/RESOLVED; onset 2022-10-04 (study day 61); relationship: not assessed
Grade 2 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2022-09-19 (study day 46); relationship: not assessed
Grade 3 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2022-09-08 (study day 35); relationship: not assessed
Grade 1 Anaemia — outcome: RECOVERED/RESOLVED; onset 2022-08-24 (study day 20); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.